M
Member
Speaking in the House of Lords on 19 March 2025
Debate
Infected Blood Compensation Scheme Regulations 2025Contribution
This is not a policy area I have worked on previously, but I have met campaigners who have raised their concerns with me. They have raised concerns that the IBCA lacks sufficient independence from government and the discretion to consider atypical personal or health impacts, such as infertility. They are uncertain about how claims will be assessed, particularly for those whose suffering does not fit neatly into predefined categories. Some have also questioned the transparency of the process by which medical conditions were recognised under the supplementary route. Others argue that the burden of proof for psychological impact claims is too high and that the long-term effects of interferon treatment are not adequately reflected in compensation sums.
About Hansard
Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.
Partner sites